NM_014780.5:c.5080T>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting

The NM_014780.5(CUL7):​c.5080T>G​(p.Phe1694Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000687 in 1,557,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

CUL7
NM_014780.5 missense

Scores

3
10
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 4.07

Publications

1 publications found
Variant links:
Genes affected
CUL7 (HGNC:21024): (cullin 7) The protein encoded by this gene is a component of an E3 ubiquitin-protein ligase complex. The encoded protein interacts with TP53, CUL9, and FBXW8 proteins. Defects in this gene are a cause of 3M syndrome type 1 (3M1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
CUL7 Gene-Disease associations (from GenCC):
  • 3M syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • 3-M syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.34245545).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000282 (43/152234) while in subpopulation AFR AF = 0.000963 (40/41542). AF 95% confidence interval is 0.000726. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CUL7NM_014780.5 linkc.5080T>G p.Phe1694Val missense_variant Exon 26 of 26 ENST00000265348.9 NP_055595.2 Q14999-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CUL7ENST00000265348.9 linkc.5080T>G p.Phe1694Val missense_variant Exon 26 of 26 1 NM_014780.5 ENSP00000265348.4 Q14999-1

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152116
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000547
AC:
9
AN:
164596
AF XY:
0.0000576
show subpopulations
Gnomad AFR exome
AF:
0.000839
Gnomad AMR exome
AF:
0.0000397
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000455
AC:
64
AN:
1405162
Hom.:
0
Cov.:
31
AF XY:
0.0000375
AC XY:
26
AN XY:
693582
show subpopulations
African (AFR)
AF:
0.00184
AC:
59
AN:
32050
American (AMR)
AF:
0.0000554
AC:
2
AN:
36092
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25210
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36370
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49766
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082062
Other (OTH)
AF:
0.0000515
AC:
3
AN:
58250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152234
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000963
AC:
40
AN:
41542
American (AMR)
AF:
0.000196
AC:
3
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000138
Hom.:
0
Bravo
AF:
0.000423
ESP6500AA
AF:
0.00160
AC:
7
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000691
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Mar 28, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1694 of the CUL7 protein (p.Phe1694Val). This variant is present in population databases (rs150979209, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with CUL7-related conditions. ClinVar contains an entry for this variant (Variation ID: 286956). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Jul 14, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5080T>G (p.F1694V) alteration is located in exon 26 (coding exon 25) of the CUL7 gene. This alteration results from a T to G substitution at nucleotide position 5080, causing the phenylalanine (F) at amino acid position 1694 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.25
T;.
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.76
T;T
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.34
T;T
MetaSVM
Uncertain
0.29
D
MutationAssessor
Benign
1.8
L;.
PhyloP100
4.1
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.99
N;N
REVEL
Uncertain
0.59
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.99
D;.
Vest4
0.76
MVP
0.91
MPC
0.83
ClinPred
0.20
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.37
gMVP
0.54
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150979209; hg19: chr6-43005443; API